METHYLPHENIDAT Mepha depotabs 18 mg bte 60 pce

7680664450026 CH-66445 N06BA04 01.10.2.

Reimbursement limitations:

FOCALIN XR

Pose du diagnostic par un médecin spécialiste (pédiatre/psychiatre), expert dans le traitement du TDAH,
Traitement …

METHYLPHENIDAT Mepha depotabs 18 mg bte 60 pce
METHYLPHENIDAT Mepha depotabs 18 mg bte 60 pce
METHYLPHENIDAT Mepha depotabs 18 mg bte 60 pce
1 / 3
google

Details

Product number
6644501
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
methylphenidati hydrochloridum 18 mg, sacchari sphaerae corresp. saccharum 10.9 mg, hypromellosum, talcum, acidum hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corresp. natrium 3.87 mg, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, E 172 (flavum), acidum hydrochloridum, pro compresso obducto.

Articles (1)

Methylphenidat-Mepha 18 mg, Retardtabletten
Tabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/05/2025
Patient information leaflet
Français
23/05/2025
Patient information leaflet
Italien
23/05/2025
Professional SmPC
Allemand
23/05/2025
Professional SmPC
Français
23/05/2025
Professional SmPC
Italien
23/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
18.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
10.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.87 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 67.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66445
Drug name
Methylphenidat-Mepha, Retardtabletten
Galenic form
RETT
ATC Code
N06BA04
Authorization status
Z
Dispensation category
A+
First authorization
09/08/2017
Authorization expiration date
31/12/9999
IT number
01.10.2.
Domain
Human medicine
Field of application
Zentral wirkendes Sympathomimetikum

Packaging details

Description (FR)
METHYLPHENIDAT Mepha depotabs 18 mg bte 60 pce
Description (DE)
METHYLPHENIDAT Mepha Depotabs 18 mg Ds 60 Stk
Market launch
09/08/2017
Narcotic (BTM)
A

Original drug

Concerta, Retardtabletten
CHF 48.35
View original

Other packaging sizes

METHYLPHENIDAT Mepha depotabs 18 mg bte 30 pce
30 TABL
View
METHYLPHENIDAT Mepha depotabs 27 mg bte 30 pce
30 TABL
View
METHYLPHENIDAT Mepha depotabs 27 mg bte 60 pce
60 TABL
View
METHYLPHENIDAT Mepha depotabs 36 mg bte 30 pce
30 TABL
View
METHYLPHENIDAT Mepha depotabs 36 mg bte 60 pce
60 TABL
View
METHYLPHENIDAT Mepha depotabs 54 mg bte 30 pce
30 TABL
View
METHYLPHENIDAT Mepha depotabs 54 mg bte 60 pce
60 TABL
View